Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. TMO.NE Peers
See (TMO.NE) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Diagnostics & Research Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| TMO.NE | CA$14.78 | +0.68% | 207.1B | 23.09 | CA$0.64 | +0.40% |
| EDT.TO | CA$0.84 | +3.70% | 239.5M | -10.50 | -CA$0.08 | N/A |
| AKU.TO | CA$0.53 | N/A | 45.2M | -0.14 | -CA$3.80 | N/A |
| SONA.CN | CA$0.39 | +5.41% | 42.3M | -13.00 | -CA$0.03 | N/A |
| BUX.CN | CA$0.33 | N/A | 30M | -16.50 | -CA$0.02 | N/A |
| IZO.CN | CA$0.27 | N/A | 14.7M | -6.75 | -CA$0.04 | N/A |
| SZLS.TO | CA$0.04 | N/A | 4.9M | -0.25 | -CA$0.16 | N/A |
| SCRN.CN | CA$0.02 | N/A | 1.5M | -0.25 | -CA$0.06 | N/A |
| MEDV.NE | CA$0.03 | +50.00% | 810.6K | -0.09 | -CA$0.35 | N/A |
Stock Comparison
TMO.NE vs EDT.TO Comparison
TMO.NE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMO.NE stands at 207.1B. In comparison, EDT.TO has a market cap of 239.5M. Regarding current trading prices, TMO.NE is priced at CA$14.78, while EDT.TO trades at CA$0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMO.NE currently has a P/E ratio of 23.09, whereas EDT.TO's P/E ratio is -10.50. In terms of profitability, TMO.NE's ROE is +0.13%, compared to EDT.TO's ROE of +0.79%. Regarding short-term risk, TMO.NE is less volatile compared to EDT.TO. This indicates potentially lower risk in terms of short-term price fluctuations for TMO.NE.